Tacrolimus Biotin Conjugate

NEMP1 Promotes Tamoxifen Resistance in Breast Cancer Cells.

A new interesting article has been published in Biochem Genet. 2019 May 11. doi: 10.1007/s10528-019-09926-0. and titled:

NEMP1 Promotes Tamoxifen Resistance in Breast Cancer Cells.

Authors of this article are:

Liu Y, Tong C, Cao J, Xiong M.

A summary of the article is shown below:

Breast cancer (BC) is a worldwide malignant and a leading death cancer in women. Studies have shown that adjuvant tamoxifen reduces the recurrence rate and metastasis in BC. Even though tamoxifen has been used for the therapy of BC for decades, the resistance of it on BC cells could not be ignored. In this study, we first established a tamoxifen-resistant BC cell line and then demonstrated the overexpression of nuclear envelope integral membrane protein 1 (NEMP1) in the tamoxifen-resistant BC cells. Moreover, through a cell viability assay combined with depletion or overexpression technology, we addressed the important role of NEMP1 for the tamoxifen resistance in BC cells. Importantly, we further revealed that NEMP1 modulated tamoxifen resistance by regulating nuclear receptor coactivator 1 (NCOA1). In general, NEMP1 shows responsibility for the resistance of tamoxifen through regulating NCOA1 in BC cells. These results broaden the understanding of the tamoxifen resistance during the chemotherapy in BC and may provide new therapy method for BC.

Check out the article’s website on Pubmed for more information:

This article is a good source of information and a good way to become familiar with topics such as: Breast cancer; Cell viability; NCOA1; NEMP1; Tamoxifen resistance.